Guanosine 3',5'-cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine

Gastroenterology. 1997 Feb;112(2):437-43. doi: 10.1053/gast.1997.v112.pm9024297.

Abstract

Background & aims: Escherichia coli heat-stable enterotoxins (STa) provoke electrogenic Cl- secretion in the intestine through a guanosine 3',5'-cyclic monophosphate (cGMP)-dependent signal transduction pathway. The cGMP receptor involved in the activation of the Cl- channel is not known with certainty but may comprise either adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase (cAK) or cGMP-dependent protein kinase (cGK) type II. The aim of this study was to discriminate between these possibilities using specific kinase inhibitors.

Methods: Intestinal electrogenic Cl- secretion was determined by measuring short-circuit current (Isc) in a Ussing chamber.

Results: The general protein kinase inhibitors staurosporine and H-8 inhibited rat cGK II activity in vitro with 50% inhibitory concentration values of 4 nmol/L and 3 mumol/L, respectively, which are lower than those reported for cAK. Both staurosporine and H-8, when added to rat proximal colon at concentrations that did not affect the Isc response to 8-bromo-cAMPS, inhibited the STa- and 8-bromo-cGMP-provoked Isc response for more than 80%. Furthermore, the relative specific cGK inhibitor Rp isomer of 8-(chlorophenylthio)-cGMP, but not the cAK inhibitor RP isomer of (Rp) 8-bromo-cAMPS, inhibited the Isc response to submaximal levels of STa in rat proximal colon.

Conclusions: These data provide further evidence for an important role of cGK II in STa-mediated Cl- secretion in native rat intestinal epithelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Chlorides / metabolism*
  • Chlorides / physiology
  • Colon / drug effects
  • Colon / enzymology
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / physiology
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP-Dependent Protein Kinases / physiology*
  • Drug Stability
  • Electric Conductivity
  • Enterotoxins / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli
  • Hot Temperature
  • Intestinal Mucosa / metabolism*
  • Intestines / drug effects*
  • Isoquinolines / pharmacology
  • Male
  • Rats
  • Rats, Wistar
  • Staurosporine / pharmacology
  • Thionucleotides / pharmacology

Substances

  • Chlorides
  • Enterotoxins
  • Enzyme Inhibitors
  • Isoquinolines
  • Thionucleotides
  • 8-Bromo Cyclic Adenosine Monophosphate
  • 8-bromocyclic GMP
  • 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP
  • N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases
  • Cyclic GMP-Dependent Protein Kinases
  • Cyclic GMP
  • Staurosporine